Global and China Plasma Fraction Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Plasma Fraction Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Protease Inhibitors
- 1.2.3 Protease
- 1.2.4 Fibrinolytic Proteins
- 1.2.5 Coagulation Factors
- 1.2.6 Anti-Coagulant Proteins
- 1.3 Market by Application
- 1.3.1 Global Plasma Fraction Market Share by Application: 2020 VS 2026
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Ambulatory Surgical Centers
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Plasma Fraction Market Perspective (2015-2026)
- 2.2 Global Plasma Fraction Growth Trends by Regions
- 2.2.1 Plasma Fraction Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Plasma Fraction Historic Market Share by Regions (2015-2020)
- 2.2.3 Plasma Fraction Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Plasma Fraction Players by Market Size
- 3.1.1 Global Top Plasma Fraction Players by Revenue (2015-2020)
- 3.1.2 Global Plasma Fraction Revenue Market Share by Players (2015-2020)
- 3.2 Global Plasma Fraction Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Plasma Fraction Revenue
- 3.4 Global Plasma Fraction Market Concentration Ratio
- 3.4.1 Global Plasma Fraction Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Plasma Fraction Revenue in 2019
- 3.5 Key Players Plasma Fraction Area Served
- 3.6 Key Players Plasma Fraction Product Solution and Service
- 3.7 Date of Enter into Plasma Fraction Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Fraction Breakdown Data by Type (2015-2026)
- 4.1 Global Plasma Fraction Historic Market Size by Type (2015-2020)
- 4.2 Global Plasma Fraction Forecasted Market Size by Type (2021-2026)
5 Plasma Fraction Breakdown Data by Application (2015-2026)
- 5.1 Global Plasma Fraction Historic Market Size by Application (2015-2020)
- 5.2 Global Plasma Fraction Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Plasma Fraction Market Size (2015-2026)
- 6.2 North America Plasma Fraction Market Size by Type (2015-2020)
- 6.3 North America Plasma Fraction Market Size by Application (2015-2020)
- 6.4 North America Plasma Fraction Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Plasma Fraction Market Size (2015-2026)
- 7.2 Europe Plasma Fraction Market Size by Type (2015-2020)
- 7.3 Europe Plasma Fraction Market Size by Application (2015-2020)
- 7.4 Europe Plasma Fraction Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Plasma Fraction Market Size (2015-2026)
- 8.2 China Plasma Fraction Market Size by Type (2015-2020)
- 8.3 China Plasma Fraction Market Size by Application (2015-2020)
- 8.4 China Plasma Fraction Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Plasma Fraction Market Size (2015-2026)
- 9.2 Japan Plasma Fraction Market Size by Type (2015-2020)
- 9.3 Japan Plasma Fraction Market Size by Application (2015-2020)
- 9.4 Japan Plasma Fraction Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Plasma Fraction Market Size (2015-2026)
- 10.2 Southeast Asia Plasma Fraction Market Size by Type (2015-2020)
- 10.3 Southeast Asia Plasma Fraction Market Size by Application (2015-2020)
- 10.4 Southeast Asia Plasma Fraction Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
- 11.1 Baxter
- 11.1.1 Baxter Company Details
- 11.1.2 Baxter Business Overview
- 11.1.3 Baxter Plasma Fraction Introduction
- 11.1.4 Baxter Revenue in Plasma Fraction Business (2015-2020))
- 11.1.5 Baxter Recent Development
- 11.2 Octapharma
- 11.2.1 Octapharma Company Details
- 11.2.2 Octapharma Business Overview
- 11.2.3 Octapharma Plasma Fraction Introduction
- 11.2.4 Octapharma Revenue in Plasma Fraction Business (2015-2020)
- 11.2.5 Octapharma Recent Development
- 11.3 Biotest
- 11.3.1 Biotest Company Details
- 11.3.2 Biotest Business Overview
- 11.3.3 Biotest Plasma Fraction Introduction
- 11.3.4 Biotest Revenue in Plasma Fraction Business (2015-2020)
- 11.3.5 Biotest Recent Development
- 11.4 CSL
- 11.4.1 CSL Company Details
- 11.4.2 CSL Business Overview
- 11.4.3 CSL Plasma Fraction Introduction
- 11.4.4 CSL Revenue in Plasma Fraction Business (2015-2020)
- 11.4.5 CSL Recent Development
- 11.5 Grifols
- 11.5.1 Grifols Company Details
- 11.5.2 Grifols Business Overview
- 11.5.3 Grifols Plasma Fraction Introduction
- 11.5.4 Grifols Revenue in Plasma Fraction Business (2015-2020)
- 11.5.5 Grifols Recent Development
- 11.6 Kedrion
- 11.6.1 Kedrion Company Details
- 11.6.2 Kedrion Business Overview
- 11.6.3 Kedrion Plasma Fraction Introduction
- 11.6.4 Kedrion Revenue in Plasma Fraction Business (2015-2020)
- 11.6.5 Kedrion Recent Development
- 11.7 LFB
- 11.7.1 LFB Company Details
- 11.7.2 LFB Business Overview
- 11.7.3 LFB Plasma Fraction Introduction
- 11.7.4 LFB Revenue in Plasma Fraction Business (2015-2020)
- 11.7.5 LFB Recent Development
- 11.8 Chinese Biological Products
- 11.8.1 Chinese Biological Products Company Details
- 11.8.2 Chinese Biological Products Business Overview
- 11.8.3 Chinese Biological Products Plasma Fraction Introduction
- 11.8.4 Chinese Biological Products Revenue in Plasma Fraction Business (2015-2020)
- 11.8.5 Chinese Biological Products Recent Development
- 11.9 Shanghai RAAS Blood Products
- 11.9.1 Shanghai RAAS Blood Products Company Details
- 11.9.2 Shanghai RAAS Blood Products Business Overview
- 11.9.3 Shanghai RAAS Blood Products Plasma Fraction Introduction
- 11.9.4 Shanghai RAAS Blood Products Revenue in Plasma Fraction Business (2015-2020)
- 11.9.5 Shanghai RAAS Blood Products Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Global Plasma Fraction Scope and Market Size
Plasma Fraction market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Fraction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Protease Inhibitors
Protease
Fibrinolytic Proteins
Coagulation Factors
Anti-Coagulant Proteins
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Based on regional and country-level analysis, the Plasma Fraction market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Plasma Fraction market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Baxter
Octapharma
Biotest
CSL
Grifols
Kedrion
LFB
Chinese Biological Products
Shanghai RAAS Blood Products